GO Therapeutics
PrivateLast Round
Series A
Sep 25, 2017
Total Funding Raised
$10M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GO Therapeutics is a biotechnology company that develops antibody-based cancer therapeutics by targeting O-linked glycoproteins specific to cancer cells for a broad array of potent cancer-killing modalities.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GO Therapeutics Comparables
Compare GO Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Combotope Therapeutics | 85% | |
| GlyTR Therapeutics | 84% | |
| Glycotope GmbH | 83% | |
GO Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 25, 2017 | ||||
| Series A | Aug 16, 2017 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 169% MoM.
- Dec 9, 2025
Monthly visitors increased 73% MoM.
GO Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GO Therapeutics's valuation, stock price, and market status.